Status:
WITHDRAWN
Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033
Lead Sponsor:
Pfizer
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether fenofibrate effects the toleration, safety, or efficacy biomarkers of CP-742,033, a drug being developed for the treatment of obesity.
Eligibility Criteria
Inclusion
- BMI of 30-40 kg/m2
Exclusion
- Women of childbearing potential
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00376285
Start Date
November 1 2006
Last Update
April 22 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.